Summit Therapeutics Jumps on $2 Billion AstraZeneca Deal
Summit Therapeutics shares increased following a $2 billion strategic equity investment from AstraZeneca to co-develop cancer drugs.
Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.
READ NEXT
More on the wire
AI TLDR
A recent nor'easter caused significant beach erosion at Rockaway Beach, leaving the shoreline looking like steep cliffs. Local reports indicate that much of the sand was displaced toward Breezy Point.
AI TLDR
President Trump announced a voluntary accord signed by tech leaders regarding the development of artificial intelligence. The president described the agreement as a constitution for safe AI development.
AI TLDR
Authorities are investigating whether Iran was involved in a potential plot to target a British air base used by the U.S. Air Force. Five men were arrested and subsequently released in connection with the incident.